Sana Biotechnology Inc
(NAS:SANA)
$
6.91
-0.06 (-0.86%)
Market Cap: 1.53 Bil
Enterprise Value: 1.34 Bil
PE Ratio: 0
PB Ratio: 4.07
GF Score: 39/100 Sana Biotechnology Inc at Bank of America Healthcare Conference Transcript
May 11, 2022 / 10:20PM GMT
Release Date Price:
$5.4
(-13.46%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Welcome to the second day of the afternoon session of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here, and we're thrilled to have Sana Biotech, President and CEO, Steve Harr. Steve, welcome.
Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director
Thank you, Geoff. It's super fun to see you and people in person. It's been a long time.
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Yes. It has been a long time. Well, to start off with sort of a 30,000 foot view, you guys. There's a lot going on, different technologies. I know you can be a little long-winded, so I'll just say...
Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director
It can be. It can be.
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot